A detailed history of Vital Stone Financial, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vital Stone Financial, LLC holds 98 shares of BMY stock, worth $5,660. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98
Previous 98 -0.0%
Holding current value
$5,660
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $19,828 - $23,660
-409 Reduced 80.67%
98 $5,000
Q2 2023

Aug 21, 2023

SELL
$63.71 - $70.74 $1.12 Million - $1.24 Million
-17,556 Reduced 97.19%
507 $35,000
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $1.15 Million - $1.31 Million
17,556 Added 3462.72%
18,063 $1.13 Million
Q4 2022

Jan 30, 2023

BUY
$68.48 - $81.09 $34,719 - $41,112
507 New
507 $36 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Vital Stone Financial, LLC Portfolio

Follow Vital Stone Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vital Stone Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vital Stone Financial, LLC with notifications on news.